Status of myocardial antioxidants in ischemia-reperfusion injury

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 446-456

  Dhalla, Naranjan S ^a,b   Elmoselhi, Adel B ^a,b   Hata, Tomoji ^c   Makino, Naoki ^c  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Contractile function; Coronary disease; Free radicals; Ischemia

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR; BETA CAROTENE; CATALASE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOL; UBIDECARENONE;

APOPTOSIS; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CATALASE; GLUTATHIONE PEROXIDASE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 0034683031     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00078-X     Document Type: Review

References (130)

1. Goldhaber J.I., Weiss J.N. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension. 20:1992;118-127.
2. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 79:1999;609-634.
3. Braunwald E., Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 66:1982;1146-1149.
4. Hess M.L., Barnhart G.R., Crute S., Komwatana P., Krause S., Greenfield L.J. Mechanical and biochemical effects of transient myocardial ischemia. J Surg Res. 26:1979;175-184.
5. Jeroudi M.O., Hartley C.J., Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol. 73:1994;2B-7B.
6. Limbruno U., Zucchi R., Ronca-Testoni S., Galbani P., Ronca G., Mariani M. Sarcoplasmic reticulum function in the 'stunned' myocardium. J Mol Cell Cardiol. 21:1989;1063-1072.
7. Vatner D.E., Kiuchi K., Manders W.T., Vatner S.F. Effects of coronary arterial reperfusion on beta-adrenergic receptor-adenylyl cyclase coupling. Am J Physiol. 264:1993;H196-H204.
8. Dhalla N.S., Wang X., Beamish R.E. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol. 1:1996;7-20.
9. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol. 28:(suppl 1):1996;S1-10.
10. Griendling K.K., Alexander R.W. Oxidative stress and cardiovascular disease. Circulation. 96:1997;3264-3265.
11. Kaplan P., Lehotsky J., Racay P. Role of sarcoplasmic reticulum in the contractile dysfunction during myocardial ischaemia and reperfusion. Physiol Res. 46:1997;333-339.
12. Ceconi C., Cargnoni A., Pasini E., Condorelli E., Curello S., Ferrari R. Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol. 260:1991;H1057-H1061.
13. Dhalla N.S., Panagia V., Singal P.K., Makino N., Dixon I.M., Eyolfson D.A. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol. 20:(Suppl 2):1988;3-13.
14. 2+ exchange activity in hearts subjected to hypoxia reoxygenation. Am J Physiol. 253:1987;H1026-H1034.
15. Suzuki S., Kaneko M., Chapman D.C., Dhalla N.S. Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim Biophys Acta. 1074:1997;95-100.
16. 2+ transport during oxidative stress. Mol Cell Biochem. 99:1990;125-133.
17. + ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol. 262:1992;C664-C671.
18. 2+/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol. 277:1999;C384-C391.
19. Osada M., Netticadan T., Tamura K., Dhalla N.S. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am J Physiol. 274:1998;H2025-H2034.
20. 2+ ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury. Cardiovasc Res. 36:1997;174-184.
21. Temsah R.M., Netticadan T., Chapman D., Takeda S., Mochizuki S., Dhalla N.S. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol. 277:1999;H584-H594.
22. Elmoselhi A.B., Butcher A., Samson S.E., Grover A.K. Free radicals uncouple the sodium pump in pig coronary artery. Am J Physiol. 266:1994;C720-C728.
23. 2+ pump heterogeneity in coronary artery: free radicals and IP3-sensitive and -insensitive pools. Am J Physiol. 271:1996;C1652-C1659.
24. Grover A.K., Samson S.E., Fomin V.P. Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol. 263:1992;H537-H543.
25. 2+ pump. Am J Physiol. 269:1995;C546-C553.
26. Eddy L.J., Stewart J.R., Jones H.P., Engerson T.D., McCord J.M., Downey J.M. Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol. 253:1987;H709-H711.
27. Jarasch E.D., Bruder G., Heid H.W. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand Suppl. 548:1986;39-46.
28. Arnold W.L., DeWall R.A., Kezdi P., Zwart H.H. The effect of allopurinol on the degree of early myocardial ischemia. Am Heart J. 99:1980;614-624.
29. Chambers D.E., Parks D.A., Patterson G., et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol. 17:1985;145-152.
30. Peterson D.A., Asinger R.W., Elsperger K.J., Homans D.C., Eaton J.W. Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun. 127:1985;87-93.
31. Ferrari R., Ceconi C., Curello S., et al. Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol. 17:1985;937-945.
32. Garlick P.B., Davies M.J., Hearse D.J., Slater T.F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res. 61:1987;757-760.
33. Grech E.D., Dodd N.J., Jackson M.J., Morrison W.L., Faragher E.B., Ramsdale D.R. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol. 77:1996;122-127.
34. + ATPase by hypochlorous acid. Am J Physiol. 275:1998;C826-C831.
35. Mitsos S.E., Fantone J.C., Gallagher K.P., et al. Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol. 8:1986;978-988.
36. Musat S., Dhalla N.S. Alteration in cardiac sarcolemmal ATP receptors by oxyradicals. Ann NY Acad Sci. 793:1996;1-12.
37. Slezak J., Tribulova N., Pristacova J., et al. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol. 147:1995;772-781.
38. 2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem. 186:1998;99-106.
39. 2. Am J Physiol. 274:1998;H416-H423.
40. + ATPase by oxyradical generating systems. Mol Cell Biochem. 147:1995;139-144.
41. Dhalla N.S., Golfman L., Takeda S., Takeda N., Nagano M. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can J Cardiol. 15:1999;587-593.
42. Arroyo C.M., Kramer J.H., Dickens B.F., Weglicki W.B. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett. 221:1987;101-104.
43. Bolli R., Jeroudi M.O., Patel B.S., et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA. 86:1989;4695-4699.
44. Liu P., Hock C.E., Nagele R., Wong P.Y. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 272:1997;H2327-H2336.
45. Yasmin W., Strynadka K.D., Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 33:1997;422-432.
46. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med. 25:1998;385-391.
47. Muijsers R.B., Folkerts G., Henricks P.A., Sadeghi-Hashjin G., Nijkamp F.P. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci. 60:1997;1833-1845.
48. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 268:1995;L699-L722.
49. Lin K.T., Xue J.Y., Wong P.Y. Bcl-2 blocks peroxynitrite-induced apoptosis in HL-60 cells, an association with reactive oxygen species. Inflamm Res. 46:(Suppl 2):1997;S157-S158.
50. Lin K.T., Xue J.Y., Sun F.F., Wong P.Y. Reactive oxygen species participate in peroxynitrite-induced apoptosis in HL-60 cells. Biochem Biophys Res Commun. 230:1997;115-119.
51. Lopez B.L., Liu G.L., Christopher T.A., Ma X.L. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis. 8:1997;149-153.
52. Ma X.L., Lopez B.L., Liu G.L., Christopher T.A., Ischiropoulos H. Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart. Cardiovasc Res. 36:1997;195-204.
53. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 288:1991;481-487.
54. Lopez B.L., Christopher T.A., Yue T.L., Ruffolo R., Feuerstein G.Z., Ma X.L. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology. 51:1995;165-173.
55. Nossuli T.O., Hayward R., Scalia R., Lefer A.M. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation. 96:1997;2317-2324.
56. Nossuli T.O., Hayward R., Jensen D., Scalia R., Lefer A.M. Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol. 275:1998;H509-H519.
57. Ronson R.S., Thourani V.H., Ma X.L., et al. Peroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia. Circulation. 100:1999;II384-II391.
58. Ronson R.S., Nakamura M., Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 44:1999;47-59.
59. Maulik N., Engelman R.M., Rousou J.A., Flack J.E. III, Deaton D., Das D.K. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation. 100:1999;II369-II375.
60. Kalaycioglu S., Sinci V., Imren Y., Oz E. Metoprolol prevents ischemia-reperfusion injury by reducing lipid peroxidation. Jpn Circ J. 63:1999;718-721.
61. Khaper N., Rigatto C., Seneviratne C., Li T., Singal P.K. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol. 29:1997;3335-3344.
62. Ohta H., Adachi T., Hirano K. Internalization of human extracellular-superoxide dismutase by bovine aortic endothelial cells. Free Radic Biol Med. 16:1994;501-507.
63. Steare S.E., Yellon D.M. The protective effect of heat stress against reperfusion arrhythmias in the rat. J Mol Cell Cardiol. 25:1993;1471-1481.
64. Keaney J.F.J., Simon D.I., Freedman J.E. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 13:1999;965-975.
65. Ness A.R., Powles J.W., Khaw K.T. Vitamin C and cardiovascular disease: a systematic review. J Cardiovasc Risk. 3:1996;513-521.
66. Palace V.P., Khaper N., Qin Q., Singal P.K. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 26:1999;746-761.
67. Spencer A.P., Carson D.S., Crouch M.A. Vitamin E and coronary artery disease. Arch Intern Med. 159:1999;1313-1320.
68. Miwa K., Igawa A., Nakagawa K., Hirai T., Inoue H. Consumption of vitamin E in coronary circulation in patients with variant angina. Cardiovasc Res. 41:1999;291-298.
69. Persad S., Takeda S., Panagia V., Dhalla N.S. β-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals. J Mol Cell Cardiol. 29:1997;545-558.
70. Price J.E., Fowkes F.G. Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence. Eur Heart J. 18:1997;719-727.
71. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res. 40:1999;227-238.
72. Nguyen K.N., Landmark K. [Can vitamin E prevent development of coronary heart disease?] Kan vitamin E forebygge utvikling av koronar hjertesykdom? Tidsskr or Laegeforen. 116:1996;1109-1113.
73. Tribble D.L. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C., vitamin E., and beta-carotene: A statement for healthcare professionals from the American Heart Association. Circulation. 99:1999;591-595.
74. Haramaki N., Stewart D.B., Aggarwal S., Ikeda H., Reznick A.Z., Packer L. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic Biol Med. 25:1998;329-339.
75. Chen Z., Siu B., Ho Y.S., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol. 30:1998;2281-2289.
76. Woo Y.J., Zhang J.C., Vijayasarathy C., et al. Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation. 98:1998;II255-II260.
77. Marklund L., Westman G., Lundgren E., Roos G. CuZn superoxide dismutase, Mn superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic cell lines and normal human tissue. Cancer Res. 42:1982;1955-1961.
78. Sekili S., McCay P.B., Li X.Y., et al. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial 'stunning' in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ Res. 73:1993;705-723.
79. Triana J.F., Li X.Y., Jamaluddin U., Thornby J.I., Bolli R. Postischemic myocardial 'stunning'. Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 69:1991;731-747.
80. Nohl H., Jordan W. The metabolic fate of mitochondrial hydrogen peroxide. Eur J Biochem. 111:1980;203-210.
81. Iwata T., Konno N., Yamagishita T., et al. The role of catalase as a defence mechanism against reperfusion injury [abstract]. J Mol Cell Cardiol. 25:(suppl I):1993;S104.
82. Mocanu M.M., Steare S.E., Evans M.C., Nugent J.H., Yellon D.M. Heat stress attenuates free radical release in the isolated perfused rat heart. Free Radic Biol Med. 15:1993;459-463.
83. Amrani M., Allen N.J., O'Shea J., et al. Role of catalase and heat shock protein on recovery of cardiac endothelial and mechanical function after ischemia. Cardioscience. 4:1993;193-198.
84. Karmazyn M., Mailer K., Currie R.W. Acquisition and decay of heat-shock-enhanced postischemic ventricular recovery. Am J Physiol. 259:1990;H424-H431.
85. Konorev E.A., Struck A.T., Baker J.E., et al. Intracellular catalase inhibition does not predispose rat heart to ischemia-reperfusion and hydrogen peroxide-induced injuries. Free Radic Res Commun. 19:1993;397-407.
86. Turrens J.F., Thornton J., Barnard M.L., Snyder S., Liu G., Downey J.M. Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant defenses. Am J Physiol. 262:1992;H585-H589.
87. Arduini A., Mezzetti A., Porreca E., et al. Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. Biochim Biophys Acta. 970:1988;113-121.
88. Blaustein A., Deneke S.M., Stolz R.I., Baxter D., Healey N., Fanburg B.L. Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation. 80:1989;1449-1457.
89. Le C., Van Der Walk E., Van Der Laarse A. Buthione sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack. J Mol Cell Cardiol. 25:1993;519-528.
90. Werns S.W., Fantone J.C., Ventura A., Lucchesi B.R. Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia. J Mol Cell Cardiol. 24:1992;1215-1220.
91. Konz K.H., Haap M., Hill K.E., Burk R.F., Walsh R.A. Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. J Mol Cell Cardiol. 21:1989;789-795.
92. Yoshida T., Watanabe M., Engelman D.T., et al. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol. 28:1996;1759-1767.
93. Diaz M.N., Frei B., Vita J.A., Keaney J.F.J. Antioxidants and atherosclerotic heart disease. N Engl J Med. 337:1997;408-416.
94. Sethi R, Takeda N, Nagano M, Dhalla NS. Beneficial effects of vitamin E treatment in acute myocardial infarction. J Cardiovasc Pharmacol Ther 2000 (in press).
95. Kiuchi K., Shen Y.T., Vatner S.F., Vatner D.E. Mechanisms mediating responsiveness to beta-adrenergic stimulation after coronary reperfusion in conscious dogs. Am J Physiol. 267:1994;H1578-H1588.
96. 2+-paradox). J Mol Cell Cardiol. 27:1995;513-522.
97. Persad S., Elimban V., Kaila J., Dhalla N.S. Biphasic alterations in cardiac beta-adrenoceptor signal transduction mechanism due to oxyradicals. J Pharmacol Exp Ther. 282:1997;1623-1631.
98. Thandroyen F.T., Muntz K.H., Buja L.M., Willerson J.T. Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic A. M.P. concentrations during acute myocardial ischemia and reperfusion. Circulation. 82:1990;II30-II37.
99. Karliner J.S., Stevens M.B., Honbo N., Hoffman J.I. Effects of acute ischemia in the dog on myocardial blood flow, beta receptors, and adenylate cyclase activity with and without chronic beta blockade. J Clin Invest. 83:1989;474-481.
100. Strasser R.H., Krimmer J., Braun-Dullaeus R., Marquetant R., Kubler W. Dual sensitization of the adrenergic system in early myocardial ischemia: independent regulation of the beta-adrenergic receptors and the adenylyl cyclase. J Mol Cell Cardiol. 22:1990;1405-1423.
101. Strasser R.H., Marquetant R. Sensitization of the beta-adrenergic system in acute myocardial ischaemia by a protein kinase C-dependent mechanism. Eur Heart J. 12:(suppl F):1991;48-53.
102. Devos C., Robberecht P., Nokin P., et al. Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium. Naunyn-Schmiedeberg's Arch Pharmacol. 331:1985;71-75.
103. Freissmuth M., Schutz W., Weindlmayer-Gottel M., Zimpfer M., Spiss C.K. Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system. J Cardiovasc Pharmacol. 10:1987;568-574.
104. Ihl-Vahl R., Marquetant R., Bremerich J., Strasser R.H. Regulation of beta-adrenergic receptors in acute myocardial ischemia: subtype-selective increase of mRNA specific for beta 1-adrenergic receptors. J Mol Cell Cardiol. 27:1995;437-452.
105. Kiuchi K., Shen Y.T., Vatner S.F., Vatner D.E. Mechanisms mediating responsiveness to beta-adrenergic stimulation after coronary reperfusion in conscious dogs. Am J Physiol. 267:1994;H1578-H1588.
106. Wolff A.A., Hines D.K., Karliner J.S. Preserved beta-adrenoceptor-mediated adenylyl cyclase activity despite receptor and postreceptor dysfunction in acute myocardial ischemia. Am Heart J. 128:1994;542-550.
107. Maisel A.S., Ransnas L.A., Insel P.A. Beta-adrenergic receptors and the Gs protein in myocardial ischemia and injury. Basic Res Cardiol. 85:(suppl 1):1990;47-56.
108. Ohyanagi M., Yamamoto J., Nakamura K., et al. Messenger RNA for the guanine nucleotide-binding regulatory protein (G protein) is reduced in the acute ischemic myocardium. J Mol Cell Cardiol. 27:1995;1131-1139.
109. Susanni E.E., Manders W.T., Knight D.R., Vatner D.E., Vatner S.F., Homcy C.J. One hour of myocardial ischemia decreases the activity of the stimulatory guanine-nucleotide regulatory protein Gs. Circ Res. 65:1989;1145-1150.
110. Feuerstein G.Z., Yue T.L., Cheng H.Y., Ruffolo R.R.J. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens. 11:(suppl):1993;S41-S48.
111. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
112. Aikawa R., Komuro I., Yamazaki T., et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 100:1997;1813-1821.
113. Long X., Boluyt M.O., Hipolito M.L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest. 99:1997;2635-2643.
114. Maulik N., Yoshida T., Engelman R.M., et al. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem. 186:1998;139-145.
115. Hoshida S., Kuzuya T., Fuji H., et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol. 264:1993;H33-H39.
116. Maggirwar S.B., Dhanraj D.N., Somani S.M., Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun. 201:1994;508-515.
117. Das D.K., Engelman R.M., Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res. 27:1993;578-584.
118. Zhou X., Zhai X., Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 93:1996;1177-1184.
119. Tang X.L., Qiu Y., Turrens J.F., Sun J.Z., Bolli R. Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. Am J Physiol. 273:1997;H1651-H1657.
120. Alberola A., Such L., Gil F., Zaragoza R., Morcillo E.J. Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart. Naunyn-Schmiedeberg's Arch Pharmacol. 343:1991;505-510.
121. Chen W., Gabel S., Steenbergen C., Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res. 77:1995;424-429.
122. Collis C.S., Davies M.J., Rice-Evans C. Comparison of N-methyl hexanoylhydroxamic acid, a novel antioxidant, with desferrioxamine and N-acetyl cysteine against reperfusion-induced dysfunctions in isolated rat heart. J Cardiovasc Pharmacol. 22:1993;336-342.
123. Ferrari R., Ceconi C., Curello S., et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med. 91:1991;95S-105S.
124. Cotgreave I.A. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Dies H. Antioxidants in disease mechanisms and therapy. 1997;205-221 Academic Press, San Diego.
125. Ceconi C., Curello S., Cargnoni A., Ferrari R., Albertini A., Visioli O. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol. 20:1988;5-13.
126. Tang L.D., Sun J.Z., Wu K., Sun C.P., Tang Z.M. Beneficial effects of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart. Br J Pharmacol. 102:1991;601-606.
127. Ellman G., Lysko H. A precise method for the determination of whole blood and plasma sulfhydryl groups. Anal Biochem. 93:1979;98-102.
128. Chang S.W., Lauterburg B.H., Voelkel N.F. Endotoxin causes neutrophil-independent oxidative stress in rats. J Appl Physiol. 65:1988;358-367.
129. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 27:1969;502-522.
130. 2+ pump by oxygen free radicals. Am J Physiol. 257:1989;H804-H811.